Updates from ASCO 2026: Does MRD testing present a molecular window of opportunity for pancreatic cancer?

Faculty: John Strickler, MD; Ryne Ramaker, MD, PhD
Disclosures

Faculty

VMTB Chair and Speaker

John Strickler, MD
Professor of Medicine
Co-leader, Duke Cancer Institute Molecular Tumor Board
Duke University

Speaker

Ryne Ramaker, MD, PhD
Duke Cancer Institute

Discover more from OmniOncology.net

Subscribe now to keep reading and get access to the full archive.

Continue reading